Is H Lundbeck A/S halal to invest in?

As of August 2026, H Lundbeck A/S LUNA.VI is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.

Is H Lundbeck A/S a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes H Lundbeck A/S using these criteria to determine its compliance status.

Can Muslims buy shares of H Lundbeck A/S?

Muslim investors may consider investing in H Lundbeck A/S if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is H Lundbeck A/S classified as NOT HALAL?

Musaffa determines the Shariah status of H Lundbeck A/S by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for H Lundbeck A/S updated?

The Shariah compliance status of H Lundbeck A/S may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like H Lundbeck A/S become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of H Lundbeck A/S?

You can check the latest Shariah compliance status of H Lundbeck A/S on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

H Lundbeck A/S LUNA.VI

Last Updated: Aug 07, 12:00 AM·WBAG

LUNA.VI Shariah Compliance

Screening Methodology: AAOIFI

As of August 2026, H Lundbeck A/S is classified as not halal.

NOT HALAL

Report Source: undefined Quarter Report

H Lundbeck A/S. Stock Analysis LUNA.VI

Austria Health Care Mid Cap

H Lundbeck A/S is a DK-based company operating in Pharmaceuticals industry. H Lundbeck A/S is a Denmark-based company active in the pharmaceuticals industry. The company is engaged in the research, development, manufacture and marketing of pharmaceuticals for the treatment of brain disorders, such as Alzheimer’s disease, Bipolar disorder, depression, epilepsy, Huntington’s disease, Parkinson’s disease and schizophrenia. Its product portfolio includes: Cipralex for the treatment of depression and anxiety disorders, Ebixa for the treatment of Alzheimer’s disease, Azilect for the treatment of Parkinson’s disease, Xenazine for the treatment of Huntington’s disease and Sabril for the treatment of epilepsy, among others. The firm operates through a number of subsidiaries, such as Lundbeck SAS, Lundbeck GmbH, SIA Lundbeck Latvia and Lundbeck LLC.